Publication | Open Access

Comparison of brand versus generic antiepileptic drug adverse event reporting rates in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS)

Drug SafetyU.s. FoodHealth PolicyAdverse EventPatient SafetyOutcomes ResearchDrug MonitoringMedicineAdverse Drug ReactionSide Effect